Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06745934 · ClinicalTrials.gov registry record · NA
Strengthening Health and Insight in New Educators
A NA study of Depressive Symptoms and Anxiety Symptoms, sponsored by University of Alabama, Tuscaloo.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT06745934: Recruiting NA study of Depressive Symptoms and Anxiety Symptoms, sponsored by University of Alabama, Tuscaloo.
NCT06745934 is a NA study of Depressive Symptoms and Anxiety Symptoms that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 140 participants, below the 259-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06745934, a NA study of Depressive Symptoms and Anxiety Symptoms, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
Teachers are at notable risk for depression and anxiety. The present study tests an app-based mindfulness intervention for teachers in their final year of training with the goal of preventing the deterioration of their mental health during the transition into the classroom. The project will strengthen the research environment at the University of Alabama and will involve undergraduate research assistants in each step of the research process.
Primary Outcome
Participants will self-report on depression. Each of the 8 items is rated on 1 (1 = Never) to 5 (5 = Always) scale. Responses will be summed to create the raw scale score. Higher values indicate greater symptoms of depression (i.e., a worse outcome).
Conditions Studied
Interventions
- BEHAVIORAL Healthy Minds Program
Study Locations (1)
Alabama
- University of Alabama - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-01-17 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06745934 shows while recruiting
NCT06745934 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 259-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (46% lower).
The record links to 2 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Healthy Minds Program is the first listed.
NCT06745934 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT06745934 about?
NCT06745934 is a clinical study titled "Strengthening Health and Insight in New Educators". Teachers are at notable risk for depression and anxiety. The present study tests an app-based mindfulness intervention for teachers in their final year of training with the goal of preventing the deterioration of their mental health during the transition into the classroom. The project will strength...
What is the current status of trial NCT06745934?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2025-01-17. Estimated completion is 2027-06.
What conditions does trial NCT06745934 study?
This clinical trial studies the following conditions: Depressive Symptoms, Anxiety Symptoms.
What interventions are being tested in trial NCT06745934?
The interventions under investigation include: Healthy Minds Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06745934?
This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06745934 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06745934's enrollment target sits among peer trials
140 22nd of 60 higher than 39 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI